Chapter 67. Tumor Markers in Pancreatic Malignancies

  1. Hans G. Beger MD, FACS(Hon) Founding Editor Emeritus Professor of Surgery4,
  2. Andrew L. Warshaw MD Surgeon-in-Chief Chairman5,6,
  3. Markus W. Büchler MD Chairman Head Professor of Surgery7,
  4. Richard A. Kozarek MD Director8,
  5. Markus M. Lerch MD, FRCP Professor Chair9,
  6. John P. Neoptolemos MA, MB, BChir, MD, FRCS, FMedSci Head Professor of Surgery10,11,12,
  7. Keiko Shiratori MD Chair Professor13,
  8. David C. Whitcomb MD, PhD Professor of Medicine Chief14 and
  9. Bettina M. Rau MD Coordinating Editor Associate Professor of Surgery15
  1. Fuyuhiko Motoi MD1,
  2. Shin-Ichi Egawa and
  3. Seiki Matsuno MD President of the Japanese Professor of Surgery2,3

Published Online: 4 FEB 2009

DOI: 10.1002/9781444300123.ch67

The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, Second Edition

The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, Second Edition

How to Cite

Motoi, F., Egawa, S.-I. and Matsuno, S. (2008) Tumor Markers in Pancreatic Malignancies, in The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, Second Edition (eds H. G. Beger, A. L. Warshaw, M. W. Büchler, R. A. Kozarek, M. M. Lerch, J. P. Neoptolemos, K. Shiratori, D. C. Whitcomb and B. M. Rau), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300123.ch67

Editor Information

  1. 4

    c/o Universitätsklinikum Ulm, University of Ulm, Germany

  2. 5

    Department of Surgery, Massachusetts General Hospital, Boston, MA, USA

  3. 6

    W. Gerald Austen Professor of Surgery, Harvard Medical School, Boston, MA, USA

  4. 7

    Department of General and Visceral Surgery, University of Heidelberg, Germany

  5. 8

    Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA

  6. 9

    Department of Gastroenterology, Endocrinology and Nutrition, Ernst-Moritz-Arndt University, Greifswald, Germany

  7. 10

    The Owen and Ellen Evans Chair of Cancer Studies, University of Liverpool, UK

  8. 11

    Division of Surgery and Oncology, University of Liverpool, UK

  9. 12

    School of Cancer Studies, University of Liverpool, UK

  10. 13

    Department of Gastroenterology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan

  11. 14

    Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, PA, USA

  12. 15

    Department of General, Thoracic, Vascular and Transplantation Surgery, University of Rostock, Germany

Author Information

  1. 1

    First Department of Surgery, Tohoku University School of Medicine, Japan

  2. 2

    Pancreas Society, Sendai, Japan

  3. 3

    Tohoku Koseinenkin Hospital, Sendai, Japan

Publication History

  1. Published Online: 4 FEB 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405146647

Online ISBN: 9781444300123



  • tumor markers in pancreatic malignancies;
  • tumor marker types;
  • mucin tumor markers;
  • endothelial-cell leukocyte adhesion molecule (ELAM)-1;
  • oncofetal antigens;
  • CAM17.1/wheat-germ agglutinin (WGA);
  • pancreatic cancer enzyme assays;
  • tumor-marker assays - CA19-9, DU-PAN-2, SPan-1, and CAM17.1/WGA


This chapter contains sections titled:

  • Introduction

  • Types of tumor marker

  • Mucin tumor markers

  • Oncofetal antigens

  • Other markers

  • Role of pancreatic tumor markers in clinical practice

  • Conclusions

  • References